These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14508366)

  • 41. Steroid-free immunosuppression after renal transplantation-long-term experience from a single centre.
    El-Faramawi M; Rohr N; Jespersen B
    Nephrol Dial Transplant; 2006 Jul; 21(7):1966-73. PubMed ID: 16574678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
    Swinnen LJ; Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson MR; Heroux AL; Dizikes GJ; Pifarre R; Fisher RI
    N Engl J Med; 1990 Dec; 323(25):1723-8. PubMed ID: 2100991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
    Heo JS; Park JW; Lee KW; Lee SK; Joh JW; Kim SJ; Lee HH; Lee DS; Choi SH; Seo JM; Choe YH
    Transplant Proc; 2004 Oct; 36(8):2307-8. PubMed ID: 15561231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current induction immunosuppression and post-heart transplant lymphoproliferative disorders.
    Peraira JR; Segovia J; Fuertes B; Fernández JA; Escudier JM; Salas C; Pulpón LA
    Transplant Proc; 2003 Aug; 35(5):2009-10. PubMed ID: 12962879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-transplant lymphoproliferative disorder with supraglottic involvement.
    Rombaux P; Marque A; Hamoir M; Smets F; Sokal E
    B-ENT; 2005; 1(1):53-6. PubMed ID: 15999677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
    Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
    Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL; Marcus R; Bradley JA
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
    Elidemir O; Kancherla BS; Schecter MG; McKenzie ED; Morales DL; Heinle JS; Mallory GB
    Pediatr Transplant; 2009 Aug; 13(5):606-10. PubMed ID: 19017289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.
    Birkeland SA; Bendtzen K; Møller B; Hamilton-Dutoit S; Andersen HK
    Transplantation; 1999 Mar; 67(6):876-81. PubMed ID: 10199737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
    J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tonsil enlargement after liver transplantation in adults--reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease.
    Mucha K; Foroncewicz B; Niemczyk K; Ziarkiewicz-Wróblewska B; Stanisławek-Sut O; Zieniewicz K; Krawczyk M; Paczek L
    Liver Transpl; 2007 Jun; 13(6):918-23. PubMed ID: 17539016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation.
    Cao S; Cox K; Esquivel CO; Berquist W; Concepcion W; Ojogho O; Monge H; Krams S; Martinez O; So S
    Transplantation; 1998 Oct; 66(7):851-6. PubMed ID: 9798693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center.
    Cockfield SM; Preiksaitis JK; Jewell LD; Parfrey NA
    Transplantation; 1993 Jul; 56(1):88-96. PubMed ID: 8333073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.
    Libertiny G; Watson CJ; Gray DW; Welsh KI; Morris PJ
    Br J Surg; 2001 Oct; 88(10):1330-4. PubMed ID: 11578286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen.
    Agüero J; Almenar L; Martinez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Izquierdo M; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2558-9. PubMed ID: 17098001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients.
    Levine SM; Angel L; Anzueto A; Susanto I; Peters JI; Sako EY; Bryan CL
    Chest; 1999 Nov; 116(5):1273-7. PubMed ID: 10559086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD).
    Sasaki TM; Pirsch JD; D'Alessandro AM; Knechtle SJ; Kalayoglu M; Hafez GR; Sollinger HW
    Clin Transplant; 1997 Feb; 11(1):29-33. PubMed ID: 9067691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.